Successful Medical Management of Recalcitrant Fusarium solani Keratitis: Molecular Identification and Susceptibility Patterns

Mycopathologia

Volumn 174, Issue 3, 2012, Pages 233-237

  Taylan Sekeroglu, Hande ^a   Erdem, Elif ^a   Yagmur, Meltem ^a   Gumral, Ramazan ^b   Ersoz, Reha ^a   Ilkit, Macit ^a   Harbiyeli, Ibrahim Inan ^a  

^a CUKUROVA UNIVERSITY   (Turkey)

^b GULHANE SCHOOL OF MEDICINE   (Turkey)

Author keywords

Amphotericin B; Caspofungin; Fungal keratitis; Fusarium solani; Intrastromal injection; Voriconazole

Indexed keywords

ANTIFUNGAL AGENT;

ADOLESCENT; ARTICLE; CASE REPORT; CLASSIFICATION; FUSARIOSIS; FUSARIUM; HUMAN; INJECTION; ISOLATION AND PURIFICATION; KERATITIS; MALE; MICROBIOLOGICAL EXAMINATION; MICROBIOLOGY; TREATMENT OUTCOME;

ADOLESCENT; ANTIFUNGAL AGENTS; FUSARIOSIS; FUSARIUM; HUMANS; INJECTIONS; KERATITIS; MALE; MICROBIAL SENSITIVITY TESTS; TREATMENT OUTCOME;

BACTERIA (MICROORGANISMS); FUNGI; FUSARIUM SOLANI;

EID: 84864278061     PISSN: 0301486X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11046-012-9542-y     Document Type: Article

References (27)

1. Kalkanci A, Ozdek S. Ocular fungal infections. Curr Eye Res. 2011; 36: 179-89.
2. Ritterband DC, Seedor JA, Shah MK, Koplin RS, McCormick SA. Fungal keratitis at the New York eye and ear infirmary. Cornea. 2006; 25: 264-7.
3. Turin L, Riva F, Galbiati G, Cainelli T. Fast, simple and highly sensitive double-rounded polymerase chain reaction assay to detect medically relevant fungi in dermatological specimens. Eur J Clin Invest. 2000; 30: 511-8.
4. Hall TA. BioEdit: a user-friendly biological sequence alignment editor and analysis program for Windows 95/98 NT. Nucl Acids Symp Ser. 1999; 41: 95-8.
5. Clinical and Laboratory Standards Institute (CLSI). Reference method for broth dilution antifungal susceptibility testing of filamentous fungi. Approved Standard M38-A2. 2nd ed. Wayne, PA: CLSI; 2008.
6. Iqbal N, Boey A, Park BJ, Brandt ME. Determination of in vitro susceptibility of ocular Fusarium spp. isolates from keratitis cases and comparison of Clinical and Laboratory Standards Institute M38-A2 and E test methods. Diagn Microbiol Infect Dis. 2008; 62: 348-50.
7. Zhang N, O'Donnell K, Sutton DA, et al. Members of the Fusarium solani complex that cause infections in both humans and plants are common in the environment. J Clin Microbiol. 2006; 44: 2186-90.
8. O'Donnell K, Sutton DA, Rinaldi MG, et al. Internet-accessible DNA sequence database for identifying fusaria from human and animal isolates. J Clin Microbiol. 2010; 48: 3708-18.
9. Ozbek Z, Kang S, Sivalingam J, et al. Voriconazole in the management of Alternaria keratitis. Cornea. 2006; 25: 242-4.
10. Bunya VY, Hammersmith KM, Rapuano CJ, Ayres BD, Cohen EJ. Topical and oral voriconazole in the treatment of fungal keratitis. Am J Ophthalmol. 2007; 143: 151-3.
11. Yavas GF, Oztürk F, Küsbeci T, et al. Antifungal efficacy of voriconazole, itraconazole and amphotericin B in experimental Fusarium solani keratitis. Graefes Arch Clin Exp Ophthalmol. 2008; 246: 275-9.
12. Yoon KC, Jeong IY, Im SK, Chae HJ, Yang SY. Therapeutic effect of intracameral amphotericin B injection in the treatment of fungal keratitis. Cornea. 2007; 26: 814-8.
13. Yilmaz S, Ture M, Maden A. Efficacy of intracameral amphotericin B injection in the management of refractory keratomycosis and endophthalmitis. Cornea. 2007; 26: 398-402.
14. Kuriakose T, Kothari M, Paul P, Jacob P, Thomas R. Intracameral amphotericin B injection in the management of deep keratomycosis. Cornea. 2002; 21: 653-6.
15. Ghate D, Edelhauser HF. Ocular drug delivery. Expert Opin Drug Deliv. 2006; 3: 275-87.
16. Lalitha P, Shapiro LB, Srinivasan M, et al. Antimicrobial susceptibility of Fusarium, Aspergillus, and other filamentous fungi isolated from keratitis. Arch Ophthalmol. 2007; 125: 789-93.
17. Vemulakonda GA, Hariprasad SM, Mieler WF, et al. Aqueous and vitreous concentrations following topical administration of 1% voriconazole in humans. Arch Ophthalmol. 2008; 126: 18-22.
18. Jain V, Borse N, Shome D, Natarajan S. Recalcitrant fungal tunnel infection treated with intrastromal injection of voriconazole. Int Ophthalmol. 2010; 30: 723-5.
19. Siatiri H, Daneshgar F, Siatiri N, Khodabande A. The effects of intrastromal voriconazole injection and topical voriconazole in the treatment of recalcitrant fusarium keratitis. Cornea. 2011; 30: 872-5.
20. Prakash G, Sharma N, Goel M, Titiyal JS, Vajpayee RB. Evaluation of intrastromal injection of voriconazole as a therapeutic adjunctive for the management of deep recalcitrant fungal keratitis. Am J Ophthalmol. 2008; 146: 56-9.
21. Hurtado-Sarrió M, Duch-Samper A, Cisneros-Lanuza A, et al. Successful topical application of caspofungin in the treatment of fungal keratitis refractory to voriconazole. Arch Ophthalmol. 2010; 128: 941-2.
22. Neoh CF, Leung L, Vajpayee RB, Stewart K, Kong DC. Treatment of Alternaria keratitis with intrastromal and topical caspofungin in combination with intrastromal, topical, and oral voriconazole. Ann Pharmacother. 2011; 45: e24.
23. Li L, Wang Z, Li R, Luo S, Sun X. In vitro evaluation of combination antifungal activity against Fusarium species isolated from ocular tissues of keratomycosis patients. Am J Ophthalmol. 2008; 146: 724-8.
24. Mahdy RA, Nada WM, Wageh MM, et al. Assessment safety and efficacy of a combination therapy of topical amphotericin B and subconjunctival fluconazole for the treatment of fungal keratitis. Cutan Ocul Toxicol. 2010; 29: 193-7.
25. O'Brien TP. Therapy of ocular fungal infections. In: ocular infections: update on therapy. Ophthalmol Clin North Am. 1999; 12: 33-41.
26. Tu EY, McCartney DL, Beatty RF, Springer KL, Levy J, Edward D. Successful treatment of resistant ocular fusariosis with posaconazole (SCH-56592). Am J Ophthalmol. 2007; 143: 222-7.
27. Sponsel WE, Graybill JR, Nevarez HL, Dang D. Ocular and systemic posaconazole (SCH-56592) treatment of invasive Fusarium solani keratitis and endophthalmitis. Br J Ophthalmol. 2002; 86: 829-30.